| 1 | [SID49826718] | Active | AC50 | 0.908 | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_Dose_CherryPick_Activity [AID504725, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | AC50 | 0.908 [uM] | | BioAssay | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_Dose_CherryPick_Activity | | AID | 504725 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 2 | [SID49826718] | Active | AC50 | 1.727 | C-LANA Counter Screen: DNA intercalators Measured in Biochemical System Using Plate Reader - 2117-02_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504727, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | AC50 | 1.727 [uM] | | BioAssay | C-LANA Counter Screen: DNA intercalators Measured in Biochemical System Using Plate Reader - 2117-02_Inhibitor_Dose_CherryPick_Activity_Set2 | | AID | 504727 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 3 | [SID49826718] | Active | EC50 | 5.377 | Counterscreen for IDE activators: Fluorescence polarization-based biochemical high throughput dose response assay to identify fluorescent artifacts and/or optically active compounds [AID588442, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | EC50 | 5.377 [uM] | | BioAssay | Counterscreen for IDE activators: Fluorescence polarization-based biochemical high throughput dose response assay to identify fluorescent artifacts and/or optically active compounds | | AID | 588442 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID49826718] | Active | | | Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the RanGTP-Importin-beta complex [AID2216, Type: screening] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the RanGTP-Importin-beta complex | | AID | 2216 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID49826718] | Active | | | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line [AID463079, Type: screening] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line | | AID | 463079 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID49826718] | Active | | | Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line [AID602248, Type: screening] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line | | AID | 602248 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID49826718] | Active | | | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity [AID504423, Type: screening] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504423 | | BioAssay type | screening | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 8 | [SID49826718] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624127, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624127 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 9 | [SID49826718] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624127, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624127 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 10 | [SID49826718] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624127, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624127 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 11 | [SID49826718] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 12 | [SID49826718] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 13 | [SID49826718] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 14 | [SID49826718] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 15 | [SID49826718] | Active | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 16 | [SID49826718] | Active | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 17 | [SID49826718] | Active | | | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) [AID2797, Type: screening] | vasopressin V1a receptor [Homo sapiens] [gi:4502331] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) | | AID | 2797 | | BioAssay type | screening | | Target | vasopressin V1a receptor [Homo sapiens] [gi:4502331] | | PubMed | | | Data Table |  |
|
| 18 | [SID49826718] | Active | | | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) [AID2797, Type: screening] | vasopressin V1a receptor [Homo sapiens] [gi:4502331] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) | | AID | 2797 | | BioAssay type | screening | | Target | vasopressin V1a receptor [Homo sapiens] [gi:4502331] | | PubMed | | | Data Table |  |
|
| 19 | [SID49826718] | Active | | | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) [AID2797, Type: screening] | vasopressin V1a receptor [Homo sapiens] [gi:4502331] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) | | AID | 2797 | | BioAssay type | screening | | Target | vasopressin V1a receptor [Homo sapiens] [gi:4502331] | | PubMed | | | Data Table |  |
|
| 20 | [SID49826718] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2129, Type: screening] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2129 | | BioAssay type | screening | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|
| 21 | [SID49826718] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2129, Type: screening] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2129 | | BioAssay type | screening | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|
| 22 | [SID49826718] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2129, Type: screening] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2129 | | BioAssay type | screening | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|
| 23 | [SID49826718] | Active | | | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2166, Type: screening] | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2166 | | BioAssay type | screening | | Target | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] | | PubMed | | | Data Table |  |
|
| 24 | [SID49826718] | Active | | | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2166, Type: screening] | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2166 | | BioAssay type | screening | | Target | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] | | PubMed | | | Data Table |  |
|
| 25 | [SID49826718] | Active | | | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2166, Type: screening] | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2166 | | BioAssay type | screening | | Target | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] | | PubMed | | | Data Table |  |
|
| 26 | [SID49826718] | Active | | | Epi-absorbance-based confirmation assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase. [AID2189, Type: screening] | metallo-beta-lactamase IMP-1 [Pseudomonas aeruginosa] [gi:27368096] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Epi-absorbance-based confirmation assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase. | | AID | 2189 | | BioAssay type | screening | | Target | metallo-beta-lactamase IMP-1 [Pseudomonas aeruginosa] [gi:27368096] | | PubMed | | | Data Table |  |
|
| 27 | [SID49826718] | Active | | | Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase [AID1556, Type: screening] | metallo-beta-lactamase IMP-1 [Pseudomonas aeruginosa] [gi:27368096] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase | | AID | 1556 | | BioAssay type | screening | | Target | metallo-beta-lactamase IMP-1 [Pseudomonas aeruginosa] [gi:27368096] | | PubMed | | | Data Table |  |
|
| 28 | [SID49826718] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1) [AID588814, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1) | | AID | 588814 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 29 | [SID49826718] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1) [AID588814, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1) | | AID | 588814 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 30 | [SID49826718] | Active | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 31 | [SID49826718] | Active | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 32 | [SID49826718] | Active | | | Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE) [AID493087, Type: screening] | IDE gene product [Homo sapiens] [gi:155969707] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE) | | AID | 493087 | | BioAssay type | screening | | Target | IDE gene product [Homo sapiens] [gi:155969707] | | PubMed | | | Data Table |  |
|
| 33 | [SID49826718] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 34 | [SID49826718] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 35 | [SID49826718] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 36 | [SID49826718] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2168, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2168 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 37 | [SID49826718] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2168, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2168 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 38 | [SID49826718] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2168, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2168 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 39 | [SID49826718] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3) [AID492972, Type: screening] | platelet-activating factor acetylhydrolase IB subunit gamma [Homo sapiens] [gi:225543099] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3) | | AID | 492972 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase IB subunit gamma [Homo sapiens] [gi:225543099] | | PubMed | | | Data Table |  |
|
| 40 | [SID49826718] | Active | | | Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2 Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity [AID504523, Type: screening] | KEAP1 gene product [Homo sapiens] [gi:45269145] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2 Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504523 | | BioAssay type | screening | | Target | KEAP1 gene product [Homo sapiens] [gi:45269145] | | PubMed | | | Data Table |  |
|
| 41 | [SID49826718] | Active | | | Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2 Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity [AID504523, Type: screening] | KEAP1 gene product [Homo sapiens] [gi:45269145] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2 Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504523 | | BioAssay type | screening | | Target | KEAP1 gene product [Homo sapiens] [gi:45269145] | | PubMed | | | Data Table |  |
|
| 42 | [SID49826718] | Active | | | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). [AID2435, Type: screening] | oxytocin receptor [Homo sapiens] [gi:32307152] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). | | AID | 2435 | | BioAssay type | screening | | Target | oxytocin receptor [Homo sapiens] [gi:32307152] | | PubMed | | | Data Table |  |
|
| 43 | [SID49826718] | Active | | | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). [AID2435, Type: screening] | oxytocin receptor [Homo sapiens] [gi:32307152] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). | | AID | 2435 | | BioAssay type | screening | | Target | oxytocin receptor [Homo sapiens] [gi:32307152] | | PubMed | | | Data Table |  |
|
| 44 | [SID49826718] | Active | | | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). [AID2435, Type: screening] | oxytocin receptor [Homo sapiens] [gi:32307152] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). | | AID | 2435 | | BioAssay type | screening | | Target | oxytocin receptor [Homo sapiens] [gi:32307152] | | PubMed | | | Data Table |  |
|
| 45 | [SID49826718] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) [AID485272, Type: screening] | PADI4 gene product [Homo sapiens] [gi:216548487] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) | | AID | 485272 | | BioAssay type | screening | | Target | PADI4 gene product [Homo sapiens] [gi:216548487] | | PubMed | | | Data Table |  |
|
| 46 | [SID49826718] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) [AID485272, Type: screening] | PADI4 gene product [Homo sapiens] [gi:216548487] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) | | AID | 485272 | | BioAssay type | screening | | Target | PADI4 gene product [Homo sapiens] [gi:216548487] | | PubMed | | | Data Table |  |
|
| 47 | [SID49826718] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels [AID2642, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 2642 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 48 | [SID49826718] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction. [AID2280, Type: screening] | defective in Germ Line Development family member (gld-1) [Caenorhabditis elegans] [gi:17507875] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction. | | AID | 2280 | | BioAssay type | screening | | Target | defective in Germ Line Development family member (gld-1) [Caenorhabditis elegans] [gi:17507875] | | PubMed | | | Data Table |  |
|
| 49 | [SID49826718] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon) [AID602123, Type: screening] | DNA-binding ATP-dependent protease La [Escherichia coli str. K-12 substr. MG1655] [gi:16128424] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon) | | AID | 602123 | | BioAssay type | screening | | Target | DNA-binding ATP-dependent protease La [Escherichia coli str. K-12 substr. MG1655] [gi:16128424] | | PubMed | | | Data Table |  |
|
| 50 | [SID49826718] | Active | | | Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6 [AID504406, Type: screening] | glf gene product [Mycobacterium tuberculosis H37Rv] [gi:15610945] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49826718 | | CID | 7946312 | | Outcome | Active | | BioAssay | Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6 | | AID | 504406 | | BioAssay type | screening | | Target | glf gene product [Mycobacterium tuberculosis H37Rv] [gi:15610945] | | PubMed | | | Data Table |  |
|